Para-Retinal Administration of AAV204, a Novel AAV Capsid for the Treatment of Inherited Retinal Dystrophies, in Non-Human Primates

被引：0
|
作者：
Kevany, Brian [1 ]
Kerns, Scott [1 ]
Padegimas, Linas [1 ]
机构：
[1] Abeona Therapeut Inc, Cleveland, OH USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
925
引用
收藏
页码：436 / 437
页数：2
相关论文
共 50 条
  • [41] Subfoveal Injections in Non-Human Primates: Safety and Efficacy Following Administration of a Photoreceptor-Targeted AAV5
    Boyd, Ryan F.
    Bartoe, Joshua T.
    Vihtelic, Thomas S.
    Boye, Sanford L.
    Boye, Shannon Elizabeth
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [42] Successful repeated hepatic gene delivery in mice and non-human primates achieved by sequential administration of AAV2/5 and AAV1 vector serotypes
    Majowicz, Anna
    Salas, David
    Aseguinolaza, Gloria Gonzalez
    Petry, Harald
    Ferreira, Valerie
    HUMAN GENE THERAPY, 2014, 25 (11) : A53 - A53
  • [43] Safety of administration of AAV2CUhCLN2, a candidate treatment for late infantile neuronal lipofuscinosis to the brain of rats and non-human primates
    Hackett, NR
    Redmond, DE
    Sondhi, D
    Giannaris, EL
    Vassallo, E
    Kaminsky, SM
    Crystal, RG
    MOLECULAR THERAPY, 2004, 9 : S165 - S165
  • [44] Systemic gene expression following intravenous administration of AAV2/9 to fetal and neonatal mice and non-human primates
    Rahim, A. A.
    Wong, A. M. S.
    Hoefer, K.
    Buckley, S. M. K.
    Mattar, C. N.
    Chan, J. K. Y.
    Cooper, J. D.
    Waddington, S. N.
    HUMAN GENE THERAPY, 2011, 22 (10) : A106 - A107
  • [45] Evolution of Blood-Brain Barrier Penetrant AAV Capsids in Non-Human Primates Using a Multiplexed Transcription Dependent Capsid Engineering Platform
    Tiffany, Matthew R.
    Frias, Stephanye
    Andrews, Lori
    Nanjaraj, Ankitha
    Bendana, Yuri
    Darst, Russell
    Wist, Stephen
    Tran, Hung
    Kennard, Kenneth
    Mueller, Sarah
    Ojala, David
    Pooler, Amy
    MOLECULAR THERAPY, 2023, 31 (04) : 573 - 573
  • [46] Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette
    Kumar, Sandeep R. P.
    Xie, Jun
    Hu, Shilang
    Ko, Jihye
    Huang, Qifeng
    Brown, Harrison C.
    Srivastava, Alok
    Markusic, David M.
    Doering, Christopher B.
    Spencer, H. Trent
    Srivastava, Arun
    Gao, Guangping
    Herzog, Roland W.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 23 : 98 - 107
  • [47] NEUTRALIZING ANTIBODY AGAINST VECTOR CAPSID AFFECTS LIVER-MEDIATED FACTOR IX EXPRESSION IN NON-HUMAN PRIMATES USING AAV VECTORS
    Mizukami, Hiroaki
    Mimuro, Jun
    Ishiwata, Akira
    Ono, Fumiko
    Yagi, Hiroya
    Urabe, Masashi
    Kume, Akihiro
    Terao, Keiji
    Yasutomi, Yasuhiro
    Sakata, Yoichi
    Ozawa, Keiya
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1061 - 1062
  • [48] A Novel Adeno-Associated Viral Variant Shows Superior Retinal Gene Delivery in Non-Human Primates and Human Retinal Cell Models
    Kotterman, Melissa
    Vazin, Tandis V.
    Beliakoff, Ghezal
    Croze, Roxanne
    Byrne, Leah
    Hassanipour, Mohammad
    Schmitt, Christopher
    Wallroth, Marco
    Quezada, Melissa
    Bosch, Aimee
    Fox, Mark
    Khoday, Devi
    Zhu, Lici
    Sullivan, Katie
    Yang, Max
    Steinsapir, Andrew
    Alcamo, Elizabeth
    Holt, Jenny
    Johnson, Leisa
    Davies, Anthony
    Francis, Peter
    Schaffer, David
    Kirn, David
    MOLECULAR THERAPY, 2017, 25 (05) : 49 - 49
  • [49] Directed Evolution of an AAV9 Library Identifies a Capsid Variant with Enhanced Brain Tropism and Liver De-Targeting in Non-Human Primates and Mice Following Systemic Administration
    Moyer, Tyler
    Graham, Kristin
    Liu, Jiachen
    Ren, Xiaoqin
    Clement, Joseph
    Bloedel, Alexis
    Kulkarni, Anupriya
    Looby, Kailyn
    Khalid, Hamza
    Amy, Bruce
    Egbuchulam, Chiso
    Laks, Dan
    Child, Matthew
    Kaur, Rupinderjit
    Sayed-Zahid, Ambreen
    Grannan, Michael
    Chung, Charlotte
    Knox, Tatiana
    Hoffman, Brett
    Kutchin, Alex
    Johnson, Amy
    Cameron, Andrew
    Grant, Kyle
    Yao, Johnny
    Pande, Nilesh
    Thompson, Jeff
    Heffner, Garrett
    Carter, Todd A.
    Nonnenmacher, Mathieu E.
    MOLECULAR THERAPY, 2023, 31 (04) : 57 - 57
  • [50] Dose-response evaluation of 9P801, an engineered AAV capsid with high BBB penetration and CNS transduction in non-human primates
    Nonnenmacher, M.
    Thompson, J.
    Pande, N.
    Hefferan, M.
    Grant, K.
    Clement, J.
    Tyson, K.
    Laguna-Torres, J.
    Kulkarni, A.
    Fiore, T.
    Natasan, J.
    Carter, T.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A29 - A29
12345